重庆华森制药股份有限公司2025年半年度权益分派实施公告

Core Viewpoint - The company, Chongqing Huason Pharmaceutical Co., Ltd., has announced its 2025 semi-annual profit distribution plan, which includes a cash dividend of RMB 0.35 per 10 shares for all shareholders, totaling approximately RMB 14.62 million [2][5]. Profit Distribution Plan - The profit distribution plan was approved by the board on August 21, 2025, following authorization from the 2024 annual shareholders' meeting held on May 21, 2025 [1][3]. - The total share capital as of June 30, 2025, is 417,596,314 shares, serving as the basis for the cash distribution [2][5]. - The distribution will not involve stock increases or bonus shares, and any undistributed profits will be carried forward to future distributions [2][5]. Taxation Details - The cash dividend of RMB 0.35 per 10 shares is subject to tax, with different rates applied based on the type of shareholder and holding period [5]. - For Hong Kong market investors and certain foreign institutions, the net cash distribution will be RMB 0.315 per 10 shares after tax [5]. Key Dates - The record date for the distribution is set for September 8, 2025, and the ex-dividend date is September 9, 2025 [5]. Distribution Method - Cash dividends will be directly credited to shareholders' accounts through their custodial securities companies on the ex-dividend date [7].